US launches next-generation vaccine platform against pandemic-prone viruses

NDO - The US Department of Health and Human Services (HHS) and the National Institutes of Health (NIH) announced on May 1 local time the launch of a new generation universal vaccine platform - "Generation Gold Standard".

The platform is based on a beta-propiolactone (BPL)-inactivated whole virus approach, a modernized version of traditional vaccine technology, according to the US National Institutes of Health . The platform is aimed at dealing with viruses that have pandemic potential.

This initiative marks a turning point toward transparency, efficiency, and comprehensive preparedness, by funding the US National Institutes of Health to internally develop universal influenza and coronavirus vaccines such as BPL-1357 and BPL-24910.

The vaccines are aimed at providing broad protection against a wide range of pandemic-prone viruses, including H5N1 avian influenza and coronaviruses including SARS-CoV-2, SARS-CoV-1 and MERS-CoV, according to the US National Institutes of Health.

“Generation Gold Standard is a paradigm shift,” said Dr. Jay Bhattacharya, Director of the National Institutes of Health. “It extends vaccine protection beyond the limits of individual strains and prepares for today’s and tomorrow’s influenza threats with traditional vaccine technology modernized for the 21st century.”

Clinical trials for a universal flu vaccine are expected to begin in 2026, with the goal of approval by the US Food and Drug Administration (FDA) in 2029.

Source: https://nhandan.vn/my-ra-mat-nen-tang-vaccine-the-he-moi-chong-cac-virus-de-gay-dai-dich-post876869.html